Login / Signup

Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patients' age: An exploratory sub-analysis of the ABPARO trial.

Peter EickholzRaphael KochThomas KocherThomas HoffmannTi-Sun KimJoerg MeyleDoğan KanerUlrich SchlagenhaufDag HarmsenInga HarksBenjamin Ehmke
Published in: Journal of clinical periodontology (2019)
The clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patients' age.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • clinical trial
  • randomized controlled trial
  • patient reported outcomes
  • drug induced
  • patient reported